Patents by Inventor Michael R Batzloff

Michael R Batzloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Antibodies, Antibody Fragments And Antibody Conjugates
    Publication number: 20110064745
    Abstract: The present invention provides compositions, including pharmaceutical compositions, comprising an amount of an antibody, antibody fragment or antibody conjugate sufficient to treat Group A streptococcus (GAS) infection or complication thereof in a subject or a disease or complication associated with GAS infection in a subject wherein said antibody, antibody fragment or antibody conjugate binds immunospecifically to a B-cell epitope of GAS M-protein. The present invention also provides methods for the prophylactic or therapeutic treatment of infection by GAS and complications thereof comprising administering the compositions to a subject in need thereof.
    Type: Application
    Filed: August 23, 2010
    Publication date: March 17, 2011
    Inventors: Michael F. Good, Michael R. Batzloff, Manisha Pandey
  • SYNTHETIC CHIMERIC PEPTIDES
    Publication number: 20090162369
    Abstract: The present invention relates generally to chimeric peptides comprising one or more protective epitopes in a conformation enabling immunological interactivity and to vaccine compositions comprising same. The present invention is particularly directed to a chimeric peptide capable of inducing protecting antibodies against Group A streptococci.
    Type: Application
    Filed: December 11, 2008
    Publication date: June 25, 2009
    Inventors: Katin Helena Threse Nordstrom, Michael F. Good, Michael R. Batzloff
  • Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates
    Publication number: 20090010929
    Abstract: The present invention provides compositions, including pharmaceutical compositions, comprising an amount of an antibody, antibody fragment or antibody conjugate sufficient to treat Group A streptococcus (GAS) infection or complication thereof in a subject or a disease or complication associated with GAS infection in a subject wherein said antibody, antibody fragment or antibody conjugate binds immunospecifically to a B-cell epitope of GAS M-protein. The present invention also provides methods for the prophylactic or therapeutic treatment of infection by GAS and complications thereof comprising administering the compositions to a subject in need thereof.
    Type: Application
    Filed: December 4, 2007
    Publication date: January 8, 2009
    Inventors: Michael F. Good, Michael R. Batzloff, Manisha Pandey
  • Vaccine
    Patent number: 7255867
    Abstract: Effective stimulation of immune responses is achieved through the use of a group A streptococcal antigen combined with proteosome adjuvant. The compositions are provided in particular for intranasal administration. The vaccine compositions are provided for use in inducing an immune response in an individual for the treatment or prophylaxis of group A streptococcal infection in an individual, preferably via prevention or reduction of colonisation of the throat following intranasal administration.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: August 14, 2007
    Assignees: ID Biomedical Corporation of Quebec, The Council of the Queensland Institute of Medical Research
    Inventors: George H Lowell, George L White, Michael R Batzloff, David S Burt, Tomas B Leanderson, Michael F Good